Chargement en cours...
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
The decrement in plasma glucose concentration with SGLT2 inhibitors (SGLT2i) is blunted by a rise in endogenous glucose production (EGP). We investigated the ability of incretin treatment to offset the EGP increase. Subjects with type 2 diabetes (n = 36) were randomized to 1) canagliflozin (CANA), 2...
Enregistré dans:
| Publié dans: | Diabetes |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Diabetes Association
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7301339/ https://ncbi.nlm.nih.gov/pubmed/29602791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-1278 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|